EE196 Cost-Effectiveness Analysis of Dostarlimab Plus Carboplatin-Paclitaxel in Primary Advanced or Recurrent Endometrial Cancer With Deficient Mismatch Repair (dMMR) and High Microsatellite Instability (MSI-H) in France
Abstract
Authors
Thibaut de la Motte Rouge Jean Sébastien Frenel Capucine Lachaize Guillaume Laubel Ester Alessandrini Amel Zoubir Gaëlle Nachbaur Jérémy CARETTE Henri Leleu